Search

Your search keyword '"Gozzetti, Alessandro"' showing total 944 results

Search Constraints

Start Over You searched for: Author "Gozzetti, Alessandro" Remove constraint Author: "Gozzetti, Alessandro"
944 results on '"Gozzetti, Alessandro"'

Search Results

1. Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms

3. Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia

4. A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients

5. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

6. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group

7. Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial

8. POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis

9. Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia

10. Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma

11. p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation

12. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

13. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

14. Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis.

16. Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia

18. Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

19. Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.

21. Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study

23. Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients

24. P604: CHRONIC LYMPHOCYTIC LEUKEMIA CELLS ARE SENSITIVE TO THE APOLIPOPROTEIN E-MEDIATED DISRUPTION OF METABOLIC HOMEOSTASIS

25. S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY.

26. Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials

27. Hairy cell leukemia variant and WHO classification correspondence Re: 5thedition WHO classification haematolymphoid tumors: lymphoid neoplasms

28. International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

31. Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network

32. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

35. Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study

36. Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments

37. SARS‐CoV‐2 infection and vaccination in patients with hairy‐cell leukaemia

38. 796 LEFT ATRIAL STRAIN ASSOCIATION WITH FUNCTIONAL CAPACITY IN CARDIAC AMYLOIDOSIS

40. Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study

41. Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study

43. Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemia

44. Development of a distributed international patient data registry for hairy cell leukemia

46. Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study

47. P-149: Prevalence of type 1 Gaucher disease in patients with multiple myeloma: interim analysis of a prospective, multicentre, observational study

48. Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro‐prospective observational study

Catalog

Books, media, physical & digital resources